Skip to main content

Closed

RMD: ResMed Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+9.8% / yr

Operating margin34.3%

ROIC19.6%

Financially safe

Strong

Debt / equity0.13×

Interest coverage65.4×

Current ratio3.01×

Valuation

Unrated

P/E ratio20.3×

Dividend yield1.1%

ResMed Inc.

RMDNew York Stock Exchange·USD·Closed

ResMed Inc.

RMDNew York Stock Exchange·USD·Closed

$210.98

+1.16%

$210.98

+$2.42 (1.16%)

52W Range

27thpctl

Volume

0.57×avg

Mkt Cap

30.60BUSD

P/E

20.3TTM

Div Yield

1.14%ann

52W Range

27thpctl

Volume

0.57×avg

Market Cap

30.60BUSD

P/E Ratio

20.3TTM

Div Yield

1.14%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings